Skip to main content
TipRanks
Go Ultimate75% OFF

Fred Parks Insider Profile

4 Followers

Fred Parks, CEO, Director at Urologix, holds 100.00K shares in Urologix (Ticker: ULGX), holds 0.00 shares in Analogic Corp (Ticker: ALOG), holds 10.05K shares in Nuvectra (Ticker: NVTRQ).

Fred Parks's Trading History

ALOG
Analogic Corp
Dec 15, 2014―Informative Sell141.93K$0.00
NVTRQ
Nuvectra
―――$150.75
ULGX
Urologix
―CEO, Director―$1.50K

You May Also Like

Fred Parks insider profile FAQ

What is the percentage of profitable transactions made by Fred Parks?
The percentage of profitable transactions made by Fred Parks is 0%.
What is the average return per transaction made by Fred Parks?
The average return per transaction made by Fred Parks is -4.60%.
What stocks does Fred Parks hold?
Fred Parks holds: ULGX, ALOG, NVTRQ stocks.
What was Fred Parks's most profitable transaction?
Fred Parks’s most profitable transaction was an Informative Sell of ALOG stock on December 15, 2014. The return on the trade was -0.70%.
What is Fred Parks's role in Urologix?
Fred Parks's role in Urologix is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.